Approvals/TGA/CAPVAXIVE Pneumococcal 21-valent Conjugate Vaccine 0.5 mL Solution for Injection Pre-filled Syringe

Approved

STANDARD

CAPVAXIVE Pneumococcal 21-valent Conjugate Vaccine 0.5 mL Solution for Injection Pre-filled Syringe

Merck Sharp & Dohme (Australia) Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: e6eef29c5cfe96a2
Product Name: CAPVAXIVE Pneumococcal 21-valent Conjugate Vaccine 0.5 mL Solution for Injection Pre-filled Syringe
Artg Id: 429290
Artg Name: CAPVAXIVE Pneumococcal 21-valent Conjugate Vaccine 0.5 mL Solution for Injection Pre-filled Syringe
Sponsor: Merck Sharp & Dohme (Australia) Pty Ltd
Company Detail Path: /organization/merck-sharp-and-dohme-australia-pty-ltd
Artg Date: 2025-02-05
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Product Information: https://medical-cdn.nocode.com/drug_tga/c987c32240e0daf793296c3fecc36a68.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

e6eef29c5cfe96a2

Type

Standard